Stelis Biopharma’s flagship facility receives EIR from USFDA
The company is excited about the strategic progress that the company has made so far and are confident of delivering better business outcomes
The company is excited about the strategic progress that the company has made so far and are confident of delivering better business outcomes
Sacu V is priced at Rs. 19 per tablet for a dose of 50 mg (sacubitril 24 mg + valsartan 26 mg)
The divested brands include Onabet, Halovate, Sorvate, Luligee, Demelan, Aceret, Dosetil, Revize, and Powercort, and their sub-brands
This donation will allow the continuation of the cycle of vaccination for children foreseen within the national immunization program carried out by the Ministry of Public Health of Cuba
Point-of-Care solution to facilitate clinicians in quick and effective decision making
The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
New facility is based at Lonza’s Bend, Oregon (US) site, a Center of Excellence for bioavailability enhancement
The company remains committed to maintain the highest standards of compliance and will work closely with the agency to comprehensively address all the observations
The hospital will have all the modern facilities like modular OT, state of the art medical equipment, labs, etc. It will have OPD and IPD services
Dr. Reddy’s will manufacture the Active Pharmaceutical Ingredient and finished drug at its facilities approved by USFDA
Subscribe To Our Newsletter & Stay Updated